vs
高乐氏（CLX）与摩森康胜饮品公司（TAP）财务数据对比。点击上方公司名可切换其他公司
摩森康胜饮品公司的季度营收约是高乐氏的1.9倍（$3.1B vs $1.7B）。高乐氏净利率更高（9.4% vs 7.6%，领先1.8%）。高乐氏同比增速更快（0.3% vs -3.6%）。过去两年摩森康胜饮品公司的营收复合增速更高（1.2% vs -8.3%）
高乐氏是美国跨国企业，专业从事消费级与专业用途产品的生产及营销。2000年至2024年持续入选《财富》500强榜单，最新排名为第485位，旗下产品覆盖清洁护理、家居日用等多个品类，在全球消费市场拥有较高认可度。
摩森康胜饮品公司是一家美加合资的跨国饮料酿造企业，旗下拥有多款知名酒精及非酒精饮品产品线，业务覆盖全球多个国家和地区，目前在伊利诺伊州芝加哥与魁北克省蒙特利尔设有双总部。
CLX vs TAP — 直观对比
营收规模更大
TAP
是对方的1.9倍
$1.7B
营收增速更快
CLX
高出3.9%
-3.6%
净利率更高
CLX
高出1.8%
7.6%
两年增速更快
TAP
近两年复合增速
-8.3%
损益表 — Q2 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $3.1B |
| 净利润 | $157.0M | $238.3M |
| 毛利率 | 43.2% | 31.0% |
| 营业利润率 | — | 10.4% |
| 净利率 | 9.4% | 7.6% |
| 营收同比 | 0.3% | -3.6% |
| 净利润同比 | -15.6% | -17.2% |
| 每股收益（稀释后） | $1.29 | $1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLXTAP
| Q4 25 | $1.7B | $3.1B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | $2.0B | $3.7B | ||
| Q1 25 | $1.7B | $2.7B | ||
| Q4 24 | $1.7B | $3.2B | ||
| Q3 24 | $1.8B | $3.6B | ||
| Q2 24 | $1.9B | $3.8B | ||
| Q1 24 | $1.8B | $3.0B |
净利润CLXTAP
| Q4 25 | $157.0M | $238.3M | ||
| Q3 25 | — | $-2.9B | ||
| Q2 25 | $332.0M | $428.7M | ||
| Q1 25 | $186.0M | $121.0M | ||
| Q4 24 | $193.0M | $287.8M | ||
| Q3 24 | $99.0M | $199.8M | ||
| Q2 24 | $216.0M | $427.0M | ||
| Q1 24 | $-51.0M | $207.8M |
毛利率CLXTAP
| Q4 25 | 43.2% | 31.0% | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | 46.5% | 34.3% | ||
| Q1 25 | 44.6% | 31.6% | ||
| Q4 24 | 43.8% | 32.0% | ||
| Q3 24 | 45.8% | 33.4% | ||
| Q2 24 | 46.5% | 34.6% | ||
| Q1 24 | 42.2% | 31.6% |
营业利润率CLXTAP
| Q4 25 | — | 10.4% | ||
| Q3 25 | — | -98.5% | ||
| Q2 25 | 20.6% | 15.6% | ||
| Q1 25 | 15.2% | 6.9% | ||
| Q4 24 | 14.1% | 12.0% | ||
| Q3 24 | 10.0% | 12.5% | ||
| Q2 24 | 14.5% | 15.6% | ||
| Q1 24 | -2.3% | 10.3% |
净利率CLXTAP
| Q4 25 | 9.4% | 7.6% | ||
| Q3 25 | — | -84.0% | ||
| Q2 25 | 16.7% | 11.5% | ||
| Q1 25 | 11.2% | 4.5% | ||
| Q4 24 | 11.4% | 8.9% | ||
| Q3 24 | 5.6% | 5.5% | ||
| Q2 24 | 11.4% | 11.1% | ||
| Q1 24 | -2.8% | 6.8% |
每股收益（稀释后）CLXTAP
| Q4 25 | $1.29 | $1.32 | ||
| Q3 25 | — | $-14.79 | ||
| Q2 25 | $2.68 | $2.13 | ||
| Q1 25 | $1.50 | $0.59 | ||
| Q4 24 | $1.54 | $1.39 | ||
| Q3 24 | $0.80 | $0.96 | ||
| Q2 24 | $1.74 | $2.03 | ||
| Q1 24 | $-0.41 | $0.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $227.0M | $896.5M |
| 总债务越低越好 | — | $6.3B |
| 股东权益账面价值 | $-125.0M | $10.2B |
| 总资产 | $5.6B | $22.7B |
| 负债/权益比越低杠杆越低 | — | 0.61× |
8季度趋势，按日历期对齐
现金及短期投资CLXTAP
| Q4 25 | $227.0M | $896.5M | ||
| Q3 25 | — | $950.2M | ||
| Q2 25 | $167.0M | $613.8M | ||
| Q1 25 | $226.0M | $412.7M | ||
| Q4 24 | $290.0M | $969.3M | ||
| Q3 24 | $278.0M | $1.0B | ||
| Q2 24 | $202.0M | $1.6B | ||
| Q1 24 | $219.0M | $458.4M |
总债务CLXTAP
| Q4 25 | — | $6.3B | ||
| Q3 25 | — | $6.3B | ||
| Q2 25 | $2.5B | $6.3B | ||
| Q1 25 | — | $6.2B | ||
| Q4 24 | — | $6.1B | ||
| Q3 24 | — | $6.2B | ||
| Q2 24 | $2.5B | $7.0B | ||
| Q1 24 | — | $6.2B |
股东权益CLXTAP
| Q4 25 | $-125.0M | $10.2B | ||
| Q3 25 | — | $10.3B | ||
| Q2 25 | $321.0M | $13.4B | ||
| Q1 25 | $27.0M | $13.1B | ||
| Q4 24 | $-41.0M | $13.1B | ||
| Q3 24 | $60.0M | $13.3B | ||
| Q2 24 | $328.0M | $13.2B | ||
| Q1 24 | $91.0M | $13.1B |
总资产CLXTAP
| Q4 25 | $5.6B | $22.7B | ||
| Q3 25 | — | $22.9B | ||
| Q2 25 | $5.6B | $26.8B | ||
| Q1 25 | $5.5B | $25.9B | ||
| Q4 24 | $5.6B | $26.1B | ||
| Q3 24 | $5.5B | $26.6B | ||
| Q2 24 | $5.8B | $27.4B | ||
| Q1 24 | $5.8B | $26.1B |
负债/权益比CLXTAP
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.61× | ||
| Q2 25 | 7.74× | 0.47× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | 7.56× | 0.53× | ||
| Q1 24 | — | 0.47× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $540.7M |
| 自由现金流经营现金流 - 资本支出 | — | $357.8M |
| 自由现金流率自由现金流/营收 | — | 11.4% |
| 资本支出强度资本支出/营收 | — | 5.9% |
| 现金转化率经营现金流/净利润 | — | 2.27× |
| 过去12个月自由现金流最近4个季度 | — | $1.1B |
8季度趋势，按日历期对齐
经营现金流CLXTAP
| Q4 25 | — | $540.7M | ||
| Q3 25 | — | $616.1M | ||
| Q2 25 | $294.0M | $718.3M | ||
| Q1 25 | $286.0M | $-90.7M | ||
| Q4 24 | $180.0M | $494.5M | ||
| Q3 24 | $221.0M | $521.2M | ||
| Q2 24 | $340.0M | $869.2M | ||
| Q1 24 | $182.0M | $25.4M |
自由现金流CLXTAP
| Q4 25 | — | $357.8M | ||
| Q3 25 | — | $483.0M | ||
| Q2 25 | $219.0M | $555.0M | ||
| Q1 25 | $233.0M | $-328.0M | ||
| Q4 24 | $127.0M | $383.4M | ||
| Q3 24 | $182.0M | $350.4M | ||
| Q2 24 | $259.0M | $691.7M | ||
| Q1 24 | $127.0M | $-189.3M |
自由现金流率CLXTAP
| Q4 25 | — | 11.4% | ||
| Q3 25 | — | 13.9% | ||
| Q2 25 | 11.0% | 14.8% | ||
| Q1 25 | 14.0% | -12.2% | ||
| Q4 24 | 7.5% | 11.8% | ||
| Q3 24 | 10.3% | 9.7% | ||
| Q2 24 | 13.6% | 18.0% | ||
| Q1 24 | 7.0% | -6.2% |
资本支出强度CLXTAP
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | 3.8% | 4.4% | ||
| Q1 25 | 3.2% | 8.8% | ||
| Q4 24 | 3.1% | 3.4% | ||
| Q3 24 | 2.2% | 4.7% | ||
| Q2 24 | 4.3% | 4.6% | ||
| Q1 24 | 3.0% | 7.0% |
现金转化率CLXTAP
| Q4 25 | — | 2.27× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.89× | 1.68× | ||
| Q1 25 | 1.54× | -0.75× | ||
| Q4 24 | 0.93× | 1.72× | ||
| Q3 24 | 2.23× | 2.61× | ||
| Q2 24 | 1.57× | 2.04× | ||
| Q1 24 | — | 0.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLX
| Health And Wellness | $643.0M | 38% |
| Household | $419.0M | 25% |
| Lifestyle | $321.0M | 19% |
| Other | $290.0M | 17% |
TAP
暂无分部数据
